Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial

William Koltun, Anne W. Lucky, Diane Thiboutot, Minoo Niknian, Carole Sampson-Landers, Paul Korner, Joachim Marr

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences